Cargando…
“First do no harm” and the importance of prediction in oncology
Present cancer treatment strategies are based on the assumption that a therapy may work (“response”) or not work (“no-response”). However, the existing evidence suggests that current cancer treatment modalities may also have a cancer-promoting effect in part of the patients. In this paper, some rele...
Autores principales: | Characiejus, Dainius, Hodzic, Jasmina, Jacobs, John J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987560/ https://www.ncbi.nlm.nih.gov/pubmed/21151487 http://dx.doi.org/10.1007/s13167-010-0042-1 |
Ejemplares similares
-
Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012) -
Does the “new philosophy” in predictive, preventive and personalised medicine require new ethics?
por: Gefenas, Eugenijus, et al.
Publicado: (2011) -
Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
por: Zaleskis, Gintaras, et al.
Publicado: (2021) -
Treating Critical Illness: The Importance of First Doing No Harm
por: Singer, Mervyn, et al.
Publicado: (2005) -
First, do no harm
por: Marler, Thomas E., et al.
Publicado: (2017)